bosentan anhydrous has been researched along with Agenesis of Hemidiaphragm in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gómez-Meda, BC; Lemus-Varela, Mde L; Melnikov, V; Ornelas-Aguirre, JM; Soliz, A; Torres-Mendoza, BM; Zamora-Perez, AL; Zúñiga-González, GM | 1 |
| Abman, SH; Acker, SN; Gien, J; Kuhn, K; Nozik-Grayck, E; Partrick, DA; Seedorf, GJ | 1 |
| Broomé, M; Frenckner, B; Lindström, M; Radell, P | 1 |
3 other study(ies) available for bosentan anhydrous and Agenesis of Hemidiaphragm
| Article | Year |
|---|---|
Antenatal use of bosentan and/or sildenafil attenuates pulmonary features in rats with congenital diaphragmatic hernia.
Topics: Animals; Bosentan; Disease Models, Animal; Female; Hernias, Diaphragmatic, Congenital; Lung; Lung Diseases; Phenyl Ethers; Piperazines; Pregnancy; Purines; Random Allocation; Rats; Rats, Wistar; Sildenafil Citrate; Sulfonamides; Vascular Remodeling | 2014 |
Altered pulmonary artery endothelial-smooth muscle cell interactions in experimental congenital diaphragmatic hernia.
Topics: Animals; Bosentan; Catalase; Cell Proliferation; Coculture Techniques; Disease Models, Animal; Endothelial Cells; Endothelin-1; Hernias, Diaphragmatic, Congenital; Myocytes, Smooth Muscle; Pulmonary Artery; Reactive Oxygen Species; RNA, Small Interfering; Sheep; Signal Transduction; Sulfonamides; Superoxide Dismutase | 2015 |
Platelet-derived growth factor inhibition--a new treatment of pulmonary hypertension in congenital diaphragmatic hernia?
Topics: Benzamides; Bosentan; Combined Modality Therapy; Continuous Positive Airway Pressure; Diuretics; Enteral Nutrition; Extracorporeal Membrane Oxygenation; Heart Failure; Hernia, Diaphragmatic; Hernias, Diaphragmatic, Congenital; Humans; Hypertension, Pulmonary; Hypoxia; Iloprost; Imatinib Mesylate; Infant, Newborn; Male; Nitric Oxide; Piperazines; Protein Kinase Inhibitors; Purines; Pyrimidines; Receptors, Platelet-Derived Growth Factor; Sildenafil Citrate; Sulfonamides; Sulfones | 2008 |